BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 13660839)

  • 1. A factor in rheumatoid arthritic sera interfering in the zymosan assay of properdin.
    LAURELL AB
    Acta Pathol Microbiol Scand; 1959; 45(4):392-400. PubMed ID: 13660839
    [No Abstract]   [Full Text] [Related]  

  • 2. Adaptation of the zymosan assay of properdin to animal sera.
    KENT JF; TOUSSAINT AJ; HOOK WA
    Proc Soc Exp Biol Med; 1957 Dec; 96(3):676-8. PubMed ID: 13505826
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison between properdin titers obtained in the zymosan assay and in the bacteriophage-neutralization assay. 1. investigation on normal human sera.
    LAURELL AB; REYN A
    Acta Pathol Microbiol Scand; 1959; 47():405-18. PubMed ID: 14414558
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison between properdin titers obtained in the zymosan assay and in the bacterio-phage-neutralization assay. 2. Investigation on pathological sera.
    LAURELL AB; REYN A
    Acta Pathol Microbiol Scand; 1959; 47():419-28. PubMed ID: 14414557
    [No Abstract]   [Full Text] [Related]  

  • 5. [Interrelations of zymosan, properdin & tumors. III. Behavior of the properdin level in benzopyrene sarcoma-bearing rats treated with zymosan].
    FUMAROLA D; MODICA F
    Tumori; 1959; 45(1):46-53. PubMed ID: 13659609
    [No Abstract]   [Full Text] [Related]  

  • 6. [Relation between zymosan, properdin & tumors. I. Effect of zymosan on the development of benzpyrene-induced sarcomas].
    MODICA F
    Tumori; 1958; 44(6):538-48. PubMed ID: 13635872
    [No Abstract]   [Full Text] [Related]  

  • 7. The possible role of the properdin system in transplantable cancer; the effect of zymosan on transplantable human carcinoma.
    HERBUT PA; KRAEMER WH
    Cancer Res; 1956 Dec; 16(11):1048-52. PubMed ID: 13383472
    [No Abstract]   [Full Text] [Related]  

  • 8. The properdin system and immunity. III. The zymosan assay of properdin.
    PILLEMER L; BLUM L; LEPOW IH; WURZ L; TODD EW
    J Exp Med; 1956 Jan; 103(1):1-13. PubMed ID: 13278451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement, complement components, properdin and agglutination promoting factors in rheumatoid arthritis.
    LAURELL AB; GRUBB R
    Acta Pathol Microbiol Scand; 1958; 43(3):310-20. PubMed ID: 13594447
    [No Abstract]   [Full Text] [Related]  

  • 10. EVIDENCE FOR IMMUNOLOGICAL SPECIFICITY OF THE PROPERDIN SYSTEM; DEMONSTRATION, ISOLATION AND PROPERTIES OF A SERUM FACTOR WHICH INTERACTS WITH ZYMOSAN AND OTHER POLYSACCHARIDES AT 0 DEGREES CENTIGRADE.
    BLUM L
    J Immunol; 1964 Jan; 92():61-72. PubMed ID: 14139548
    [No Abstract]   [Full Text] [Related]  

  • 11. [Validity and limitations in the determination of serum properdin by means of zymosan].
    ZANUSSI C; TASCHINI P; SELVA G; ORTOLANI C
    Boll Ist Sieroter Milan; 1958; 37(5-6):237-45. PubMed ID: 13560652
    [No Abstract]   [Full Text] [Related]  

  • 12. Quantitative studies on the properdin-complement system. II. Kinetics of the reaction between properdin and zymosan.
    LEON MA
    J Exp Med; 1957 May; 105(5):403-15. PubMed ID: 13428911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of properdin titers in sera of normal subjects and patients with leukemia and lymphoma by zymosan and bacteriophage assavs.
    BALTCH AL; HASSIRDJIAN A; OSBORNE W; BUNN PA
    J Lab Clin Med; 1961 Mar; 57():420-7. PubMed ID: 13686461
    [No Abstract]   [Full Text] [Related]  

  • 14. Replacement of magnesium by cobalt and manganese in the interactions of the properdin system with bacteria and with zymosan.
    WARDLAW AC; BLUM L; PILLEMER L
    J Immunol; 1958 Jul; 81(1):43-7. PubMed ID: 13563878
    [No Abstract]   [Full Text] [Related]  

  • 15. Alterations in serum properdin levels following injection of Zymosan.
    PILLEMER L; ROSS OA
    Science; 1955 May; 121(3151):732-3. PubMed ID: 14372981
    [No Abstract]   [Full Text] [Related]  

  • 16. The properdin system and immunity. XI. Studies on the interaction of zymosan with the properdin system.
    BLUM L; PILLEMER L; LEPOW IH
    Z Immun exp ther; 1959; 118():313-28. PubMed ID: 13801695
    [No Abstract]   [Full Text] [Related]  

  • 17. [The properdin system and its role in infection and immunity. I. The production of active preparations of zymosan].
    NIKITINA VD; KHOLCHEV NV; ANDREEVA ZM; SOKHINA AM; CHERNOKHVOSTOVA EV; PLETENEVA IL
    Zh Mikrobiol Epidemiol Immunobiol; 1960 Aug; 31():12-9. PubMed ID: 13729079
    [No Abstract]   [Full Text] [Related]  

  • 18. Alterations in serum lysozyme and properdin titers of mice following x-irradiation or treatment with zymosan or endotoxin.
    HOOK WA; CAREY WF; MUSCHEL LH
    J Immunol; 1960 Jun; 84():569-75. PubMed ID: 14402997
    [No Abstract]   [Full Text] [Related]  

  • 19. Depressed synovial fluid levels of properdin and properdin factor B in patients with rheumatoid arthritis.
    Ruddy S; Fearon DT; Austen KF
    Arthritis Rheum; 1975; 18(4):289-95. PubMed ID: 808229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Properdin system and its role in infection and immunity. II. Determination of biological activities of zymosan].
    ANDREEVA ZM; NIKITINA VD
    Zh Mikrobiol Epidemiol Immunobiol; 1960 Nov; 31():49-53. PubMed ID: 13683406
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.